Gregory Friedman is an Oncology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 230 publications with 3,227 citations (h-index 32); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1515 Holcombe Blvd
Houston, TX 770304000
Telephone
713-792-6161Provider last certified this registry record 5 Jul 2023.
Clinical trials
- Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas
Sponsor: M.D. Anderson Cancer Center
- Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Sponsor: M.D. Anderson Cancer Center
- HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Sponsor: Pediatric Brain Tumor Consortium
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
2 NIH research awards on record, funded 2024–2026 per NIH RePORTER. The latest:
- Targeting RNF2 to Synergize with Oncolytic Immunovirotherapy to Induce Anti-Cancer Immunity in Medulloblastoma
University of Tx Md Anderson Can Ctr
FY2026$421,361R01NS146081 - Ph1 Study of HSV G207 in Pediatric Malignant Cerebellar Tumors IND 16294 01/05/18.
University of Tx Md Anderson Can Ctr
FY2024$183,881R01FD006368
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma
Journal of Clinical Investigation
2024 - Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms
International Journal of Molecular Sciences
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”